Acumen Pharmaceuticals, Inc. (ABOS)
ABOS Stock Price Chart
Explore Acumen Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze ABOS price movements and trends.
ABOS Company Profile
Discover essential business fundamentals and corporate details for Acumen Pharmaceuticals, Inc. (ABOS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 Jul 2021
Employees
61.00
Website
https://acumenpharm.comCEO
Daniel J. O'Connell
Description
Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the clinical development stage, dedicated to discovering and advancing therapeutic solutions for Alzheimer's disease. A key focus for the company involves progressing ACU193, an investigational targeted immunotherapy drug candidate. This particular humanized monoclonal antibody is currently undergoing initial human testing in Phase I clinical trials, where it is designed to specifically target soluble amyloid-beta oligomers. The firm was established in 1996 and maintains its principal headquarters in Charlottesville, Virginia.
ABOS Financial Timeline
Browse a chronological timeline of Acumen Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Aug 2026
EPS estimate is -$0.39.
Earnings released on 12 May 2026
EPS came in at -$0.33 surpassing the estimated -$0.40 by +18.07%.
Earnings released on 26 Mar 2026
EPS came in at -$0.41 surpassing the estimated -$0.50 by +18.00%.
Earnings released on 12 Nov 2025
EPS came in at -$0.44 surpassing the estimated -$0.63 by +30.16%.
Earnings released on 12 Aug 2025
EPS came in at -$0.68 falling short of the estimated -$0.54 by -25.93%.
Earnings released on 13 May 2025
EPS came in at -$0.48 surpassing the estimated -$0.56 by +14.29%.
Earnings released on 27 Mar 2025
EPS came in at -$0.62 falling short of the estimated -$0.47 by -31.91%.
Earnings released on 12 Nov 2024
EPS came in at -$0.50 falling short of the estimated -$0.36 by -38.89%.
Earnings released on 13 Aug 2024
EPS came in at -$0.34 falling short of the estimated -$0.28 by -21.43%.
Earnings released on 14 May 2024
EPS came in at -$0.25 falling short of the estimated -$0.23 by -8.70%.
Earnings released on 26 Mar 2024
EPS came in at -$0.29 matching the estimated -$0.29, while revenue for the quarter reached $290.00k , missing expectations by -98.07%.
Earnings released on 13 Nov 2023
EPS came in at -$0.24 surpassing the estimated -$0.31 by +22.58%.
Earnings released on 8 Aug 2023
EPS came in at -$0.28 surpassing the estimated -$0.36 by +22.22%.
Earnings released on 9 May 2023
EPS came in at -$0.28 surpassing the estimated -$0.33 by +15.15%.
Earnings released on 27 Mar 2023
EPS came in at -$0.32 falling short of the estimated -$0.28 by -14.29%.
Earnings released on 14 Nov 2022
EPS came in at -$0.26 surpassing the estimated -$0.27 by +3.70%.
Earnings released on 15 Aug 2022
EPS came in at -$0.25 falling short of the estimated -$0.24 by -4.17%.
Earnings released on 16 May 2022
EPS came in at -$0.23 falling short of the estimated -$0.17 by -35.29%.
Earnings released on 28 Mar 2022
EPS came in at -$0.42 falling short of the estimated -$0.14 by -200.00%.
Earnings released on 15 Nov 2021
EPS came in at -$0.10 surpassing the estimated -$0.21 by +52.38%.
Earnings released on 16 Aug 2021
EPS came in at -$7.91 falling short of the estimated -$4.56 by -73.46%.
ABOS Stock Performance
Access detailed ABOS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
